Aims & Scope ::: Clinical Immunology, Endocrine & Metabolic Drugs

ISSN: 2212-7089 (Online)
ISSN: 2212-7070 (Print)


Volume 3, 2 Issues, 2016


Download PDF Flyer




Clinical Immunology, Endocrine & Metabolic Drugs

Aims & ScopeAbstracted/Indexed in


Submit Abstracts Online Submit Manuscripts Online

Editor-in-Chief:
Emilio Jirillo
University of Bari
Bari
Italy


View Full Editorial Board

Subscribe Purchase Articles Order Reprints

Aims & Scope

Clinical Immunology, Endocrine & Metabolic Drugs publishes original research, expert reviews, drug clinical trials and thematic issues in all core areas of translational and clinical immunology, endocrine & metabolic drug research.

The journal publishes pre-clinical and clinical studies on the development of new immunology, endocrine & metabolic agents. Clinical studies of new reported immunology, endocrine & metabolic drugs include Phase 1 - IV clinical trial studies, their designs, research methodologies, and analyses. The journal is essential reading to clinicians, toxicologists, medicinal chemists, and pharmacologists.

Advertisement
Global Biotechnology Congress 2016Drug Discovery and Therapy World Congress 2016

Webmaster Contact: urooj@benthamscience.org Copyright © 2016 Bentham Science